Self-nanoemulsifying drug delivery systems of tamoxifen citrate: Design and optimization

International Journal of Pharmaceutics

Volumn 380, Issue 1-2, 2009, Pages 133-141

  Elnaggar, Yosra S R ^a   El Massik, Magda A ^a   Abdallah, Ossama Y ^a  

^a Alexandria University Faculty of Pharmacy   (Egypt)

Author keywords

Caproyl 90; Cremophor RH40; Maisine 35 1; SNEDDS; Tamoxifen citrate

Indexed keywords

CAPROYL; CREMOPHOR; DRUG CARRIER; MAISINE; PROPYLENE GLYCOL; SURFACTANT; TAMOXIFEN CITRATE; UNCLASSIFIED DRUG;

ARTICLE; DILUTION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG EFFICACY; DRUG RELEASE; DRUG SCREENING; DRUG STRUCTURE; NANOEMULSION; PRIORITY JOURNAL; PROCESS OPTIMIZATION; SURFACE PROPERTY; SUSPENSION;

DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRUG STABILITY; EMULSIONS; EXCIPIENTS; NANOTECHNOLOGY; PARTICLE SIZE; PHASE TRANSITION; SOLUBILITY; SURFACE-ACTIVE AGENTS; TAMOXIFEN;

EID: 69749105594     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.07.015     Document Type: Article

References (22)

1. Chen M.-L. Lipid excipients and delivery systems for pharmaceutical development: a regulatory perspective. Adv. Drug Deliv. Rev. 60 (2008) 768-777
2. Cuiné J.F., Charman W.N., Pouton C.W., Edwards G.A., and Porter C.J.H. Increasing the proportional content of surfactant (Cremophor EL) relative to lipid in self-emulsifying lipid-based formulations of danazol reduces oral bioavailability in beagle dogs. Pharm. Res. 24 (2007) 748-757
3. Date A.A., and Nagarsenker M.S. Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetil. Int. J. Pharm. 329 (2007) 166-172
4. Gao S., and Singh J. In vitro percutaneous absorption enhancement of a lipophilic drug tamoxifen by terpenes. J. Control. Release 51 (1998) 193-199
5. Gursoya R.N., and Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed. Pharmacother. 58 (2004) 173-182
6. Hu Z., Tawa R., Konishi T., Shibata N., and Takada K. A novel emulsifier, Labrasol, enhances gastrointestinal absorption of gentamicin. Life Sci. 69 (2001) 2899-2910
7. Itoh K., Tozuka Y., Oguchi T., and Yamamoto K. Improvement of physicochemical properties of N-4472 part I formulation design by using self-microemulsifying system. Int. J. Pharm. 238 (2002) 153-160
8. Memisoglu-Bilensoya E., Vurala I., Bochotb A., Renoirb J.M., Ducheneb D., and Hincal A.A. Tamoxifen citrate loaded amphiphilic h-cyclodextrin nanoparticles. J. Control. Release 104 (2005) 489-496
9. Mou D., Chen H., Du D., Mao C., Wan J., Xu H., and Yang X. Hydrogel-thickened nanoemulsion system for topical delivery of lipophilic drugs. Int. J. Pharm. 353 (2008) 270-276
10. Mueller R.H., Maeder K., and Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery: a review of the state of the art. Eur. J. Pharm. Biopharm. 50 (2000) 161-177
11. Nielsen F.S., Petersen K.B., and llertz A.M. Bioavailability of probucol from lipid and surfactant based formulations in minipigs: influence of droplet size and dietary state. Eur. J. Pharm. Biopharm. 69 (2008) 553-562
12. Porter C.J.H., and Charman W.N. Intestinal lymphatic drug transport: an update. Adv. Drug Deliv. Rev. 50 (2001) 61-80
13. Porter C.J.H., Pouton C.W., Cuine J.F., and Charman W.N. Enhancing intestinal drug solubilisation using lipid-based delivery systems. Adv. Drug Deliv. Rev. 60 (2008) 673-691
14. Pouton C.W., and Porter C.J.H. Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. Adv. Drug Deliv. Rev. 60 (2008) 625-637
15. Rane S.S., and Anderson B.D. What determines drug solubility in lipid vehicles: is it predictable. Adv. Drug Deliv. Rev. 60 (2008) 638-656
16. Rao S.V.R., and Shao J. Self-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of protein drugs: formulation development. Int. J. Pharm. 362 (2008) 2-9
17. Schwendener R.A., and Schott H. Lipophilic 1-beta-d-arabinofuranosyl cytosine derivatives in liposomal formulations for oral and parenteral antileukemic therapy in the murine L1210 leukemia model. J. Cancer Res. Clin. Oncol. 122 (1996) 723-726
18. Sharma A., and Sharma U.S. Liposomes in drug delivery: progress and limitations. Int. J. Pharm. 154 (1997) 123-140
19. Shen H., and Zhong M. Preparation and evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatin. J. Pharm. Pharmacol. 58 (2006) 1183-1191
20. Shin S., Choi J., and Li X. Enhanced bioavailability of tamoxifen after oral administration of tamoxifen with quercetin in rats. Int. J. Pharm. 313 (2006) 144-149
21. Wasan E.K., Bartlett K., Gershkovich B., Sivak O., Bannoe B., Wong Z., Gagnonc J., Gatesf B., Leonb C.G., and Wasanb K.M. Development and characterization of oral lipid-based amphotericin B formulations with enhanced drug solubility, stability and antifungal activity in rats infected with Aspergillus fumigatus or Candida albicans. Int. J. Pharm. 372 (2009) 76-84
22. Zhang P., Liu Y., Feng N., and Xu J. Preparation and evaluation of self-microemulsifying drug delivery system of oridonin. Int. J. Pharm. 355 (2008) 269-276